{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T23:50:44Z","timestamp":1784937044011,"version":"3.55.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T00:00:00Z","timestamp":1612224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T00:00:00Z","timestamp":1612224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"name":"AstraZeneca (AZ) Postdoc Funding"},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R35-GM126985"],"award-info":[{"award-number":["R35-GM126985"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["P30-CA012197"],"award-info":[{"award-number":["P30-CA012197"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Digit. Med."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Immuno-oncology (IO) therapies have transformed the therapeutic landscape of non-small cell lung cancer (NSCLC). However, patient responses to IO are variable and influenced by a heterogeneous combination of health, immune, and tumor factors. There is a pressing need to discover the distinct NSCLC subgroups that influence response. We have developed a\n                    <jats:underline>dee<\/jats:underline>\n                    p\n                    <jats:underline>pa<\/jats:underline>\n                    tient graph convolutional\n                    <jats:underline>n<\/jats:underline>\n                    etwork, we call \u201cDeePaN\u201d, to discover NSCLC complexity across data modalities impacting IO benefit. DeePaN employs high-dimensional data derived from both real-world evidence (RWE)-based electronic health records (EHRs) and genomics across 1937 IO-treated NSCLC patients. DeePaN demonstrated effectiveness to stratify patients into subgroups with significantly different (\n                    <jats:italic>P<\/jats:italic>\n                    -value of 2.2\u2009\u00d7\u200910\n                    <jats:sup>\u221211<\/jats:sup>\n                    ) overall median survival of 20.35 months and 9.42 months post-IO therapy. Significant differences in IO outcome were not seen from multiple non-graph-based unsupervised methods. Furthermore, we demonstrate that patient stratification from DeePaN has the potential to augment the emerging IO biomarker of tumor mutation burden (TMB). Characterization of the subgroups discovered by DeePaN indicates potential to inform IO therapeutic insight, including the enrichment of mutated KRAS and high blood monocyte count in the IO beneficial and IO non-beneficial subgroups, respectively. Our work has proven the concept that graph-based AI is feasible and can effectively integrate high-dimensional genomic and EHR data to meaningfully stratify cancer patients on distinct clinical outcomes, with potential to inform precision oncology.\n                  <\/jats:p>","DOI":"10.1038\/s41746-021-00381-z","type":"journal-article","created":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T07:57:54Z","timestamp":1612252674000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["DeePaN: deep patient graph convolutional network integrating clinico-genomic evidence to stratify lung cancers for immunotherapy"],"prefix":"10.1038","volume":"4","author":[{"given":"Chao","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4809-0514","authenticated-orcid":false,"given":"Dong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1640-2616","authenticated-orcid":false,"given":"Jonathan R","family":"Dry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2987-1374","authenticated-orcid":false,"given":"Bolan","family":"Linghu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,2]]},"reference":[{"key":"381_CR1","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.jtho.2016.10.007","volume":"12","author":"CK Lee","year":"2017","unstructured":"Lee, C. K. et al. Checkpoint inhibitors in metastatic EGFR-mutated non\u2013small cell lung cancer\u2014a meta-analysis. J. Thorac. Oncol. 12, 403\u2013407 (2017).","journal-title":"J. Thorac. Oncol."},{"key":"381_CR2","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1093\/annonc\/mdx305","volume":"28","author":"P Aguiar Jr","year":"2017","unstructured":"Aguiar, P. Jr et al. The effect of PD-L1 testing on the cost-effectiveness and economic impact of immune checkpoint inhibitors for the second-line treatment of NSCLC. Ann. Oncol. 28, 2256\u20132263 (2017).","journal-title":"Ann. Oncol."},{"key":"381_CR3","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1097\/COC.0000000000000059","volume":"38","author":"CJ Langer","year":"2015","unstructured":"Langer, C. J. Emerging immunotherapies in the treatment of non\u2013small cell lung cancer (NSCLC): the role of immune checkpoint inhibitors. Am. J. Clin. Oncol. 38, 422\u2013430 (2015).","journal-title":"Am. J. Clin. Oncol."},{"key":"381_CR4","first-page":"5546","volume":"48","author":"CD James","year":"1988","unstructured":"James, C. D. et al. Clonal genomic alterations in glioma malignancy stages. Cancer Res. 48, 5546\u20135551 (1988).","journal-title":"Cancer Res."},{"key":"381_CR5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1053\/j.seminoncol.2016.01.002","volume":"43","author":"R Simon","year":"2016","unstructured":"Simon, R., Geyer, S., Subramanian, J. & Roychowdhury, S. The Bayesian basket design for genomic variant-driven phase II trials. Semin Oncol. 43, 13\u201318 (2016).","journal-title":"Semin Oncol."},{"key":"381_CR6","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s10549-009-0345-x","volume":"119","author":"HO Habashy","year":"2010","unstructured":"Habashy, H. O. et al. Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen. Breast Cancer Res. Treat. 119, 283 (2010).","journal-title":"Breast Cancer Res. Treat."},{"key":"381_CR7","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1200\/JCO.2004.08.158","volume":"22","author":"VA Miller","year":"2004","unstructured":"Miller, V. A. et al. Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small-cell lung cancer. J. Clin. Oncol. 22, 1103\u20131109 (2004).","journal-title":"J. Clin. Oncol."},{"key":"381_CR8","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.5858\/arpa.2010-0493-OA","volume":"135","author":"HS Shim","year":"2011","unstructured":"Shim, H. S., Lee, D. H., Park, E. J. & Kim, S. H. Histopathologic characteristics of lung adenocarcinomas with epidermal growth factor receptor mutations in the International Association for the Study of Lung Cancer\/American Thoracic Society\/European Respiratory Society lung adenocarcinoma classification. Arch. Pathol. Lab. Med. 135, 1329\u20131334 (2011).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"381_CR9","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jbi.2016.10.007","volume":"64","author":"BK Beaulieu-Jones","year":"2016","unstructured":"Beaulieu-Jones, B. K. & Greene, C. S. Semi-supervised learning of the electronic health record for phenotype stratification. J. Biomed. Inform. 64, 168\u2013178 (2016).","journal-title":"J. Biomed. Inform."},{"key":"381_CR10","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.lungcan.2012.08.007","volume":"78","author":"AB Shinagare","year":"2012","unstructured":"Shinagare, A. B. et al. Unsuspected pulmonary embolism in lung cancer patients: comparison of clinical characteristics and outcome with suspected pulmonary embolism. Lung Cancer 78, 161\u2013166 (2012).","journal-title":"Lung Cancer"},{"key":"381_CR11","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/1097-0142(19890701)64:1<74::AID-CNCR2820640113>3.0.CO;2-Q","volume":"64","author":"G Bepler","year":"1989","unstructured":"Bepler, G., Neumann, K., Holle, R., Havemann, K. & Kalbfleisch, H. Clinical relevance of histologic subtyping in small cell lung cancer. Cancer 64, 74\u201379 (1989).","journal-title":"Cancer"},{"key":"381_CR12","first-page":"2929","volume":"5","author":"X Dai","year":"2015","unstructured":"Dai, X. et al. Breast cancer intrinsic subtype classification, clinical use and future trends. Am. J. Cancer Res. 5, 2929 (2015).","journal-title":"Am. J. Cancer Res."},{"key":"381_CR13","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.lungcan.2013.07.025","volume":"82","author":"LA Pikor","year":"2013","unstructured":"Pikor, L. A., Ramnarine, V. R., Lam, S. & Lam, W. L. Genetic alterations defining NSCLC subtypes and their therapeutic implications. Lung Cancer 82, 179\u2013189 (2013).","journal-title":"Lung Cancer"},{"key":"381_CR14","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/nrclinonc.2015.90","volume":"12","author":"A Thomas","year":"2015","unstructured":"Thomas, A., Liu, S. V., Subramaniam, D. S. & Giaccone, G. Refining the treatment of NSCLC according to histological and molecular subtypes. Nat. Rev. Clin. Oncol. 12, 511 (2015).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"381_CR15","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.lungcan.2009.05.021","volume":"68","author":"M Wislez","year":"2010","unstructured":"Wislez, M. et al. Non-mucinous and mucinous subtypes of adenocarcinoma with bronchioloalveolar carcinoma features differ by biomarker expression and in the response to gefitinib. Lung Cancer 68, 185\u2013191 (2010).","journal-title":"Lung Cancer"},{"key":"381_CR16","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.cell.2013.09.041","volume":"155","author":"HS Kim","year":"2013","unstructured":"Kim, H. S., Mendiratta, S., Kim, J., Pecot, C. V. & Larsen, J. E. et al. Systematic identification of molecular subtype-selective vulnerabilities in non-small-cell lung cancer. Cell 155, 552\u2013566 (2013).","journal-title":"Cell"},{"key":"381_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-014-0475-x","volume":"16","author":"KM Timms","year":"2014","unstructured":"Timms, K. M. et al. Association of BRCA1\/2 defects with genomic scores predictive of DNA damage repair deficiency among breast cancer subtypes. Breast Cancer Res. 16, 475 (2014).","journal-title":"Breast Cancer Res."},{"key":"381_CR18","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1002\/gcc.20366","volume":"45","author":"A Bergamaschi","year":"2006","unstructured":"Bergamaschi, A. et al. Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene\u2010expression subtypes of breast cancer. Genes Chromosomes Cancer 45, 1033\u20131040 (2006).","journal-title":"Genes Chromosomes Cancer"},{"key":"381_CR19","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1200\/JCO.2016.69.2160","volume":"35","author":"DR Spigel","year":"2017","unstructured":"Spigel, D. R. et al. Results From the Phase III Randomized Trial of Onartuzumab Plus Erlotinib Versus Erlotinib in Previously Treated Stage III B or IV Non-Small-Cell Lung Cancer: METLung. J Clin Oncol 35, 412\u2013420 (2017).","journal-title":"J Clin Oncol"},{"key":"381_CR20","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.lungcan.2016.06.016","volume":"99","author":"K Shien","year":"2016","unstructured":"Shien, K., Papadimitrakopoulou, V. A. & Wistuba, I. I. Predictive biomarkers of response to PD-1\/PD-L1 immune checkpoint inhibitors in non\u2013small cell lung cancer. Lung Cancer 99, 79\u201387 (2016).","journal-title":"Lung Cancer"},{"key":"381_CR21","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1001\/jamaoncol.2016.0639","volume":"2","author":"AG Sacher","year":"2016","unstructured":"Sacher, A. G. & Gandhi, L. Biomarkers for the clinical use of PD-1\/PD-L1 inhibitors in non\u2013small-cell lung cancer: a review. JAMA Oncol. 2, 1217\u20131222 (2016).","journal-title":"JAMA Oncol."},{"key":"381_CR22","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1016\/j.fertnstert.2005.01.096","volume":"83","author":"WY Chang","year":"2005","unstructured":"Chang, W. Y., Knochenhauer, E. S., Bartolucci, A. A. & Azziz, R. Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups. Fertil. Steril. 83, 1717\u20131723 (2005).","journal-title":"Fertil. Steril."},{"key":"381_CR23","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1183\/09031936.00174408","volume":"34","author":"M Weatherall","year":"2009","unstructured":"Weatherall, M. et al. Distinct clinical phenotypes of airways disease defined by cluster analysis. Eur. Respir. J. 34, 812\u2013818 (2009).","journal-title":"Eur. Respir. J."},{"key":"381_CR24","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/MD.0b013e31827f264d","volume":"92","author":"M Shah","year":"2013","unstructured":"Shah, M. et al. The clinical phenotypes of the juvenile idiopathic inflammatory myopathies. Medicine 92, 25\u201341 (2013).","journal-title":"Medicine"},{"key":"381_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41389-019-0157-8","volume":"8","author":"F Gao","year":"2019","unstructured":"Gao, F. et al. DeepCC: a novel deep learning-based framework for cancer molecular subtype classification. Oncogenesis 8, 1\u201312 (2019).","journal-title":"Oncogenesis"},{"key":"381_CR26","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1093\/bioinformatics\/btz769","volume":"36","author":"R Chen","year":"2019","unstructured":"Chen, R., Yang, L., Goodison, S. & Sun, Y. Deep learning approach to identifying breast cancer subtypes using high-dimensional genomic data. Bioinformatics 36, 1476\u20131483 (2019).","journal-title":"Bioinformatics"},{"key":"381_CR27","doi-asserted-by":"publisher","first-page":"e201900517","DOI":"10.26508\/lsa.201900517","volume":"2","author":"J Ronen","year":"2019","unstructured":"Ronen, J., Hayat, S. & Akalin, A. Evaluation of colorectal cancer subtypes and cell lines using deep learning. Life Sci. Alliance 2, e201900517 (2019).","journal-title":"Life Sci. Alliance"},{"key":"381_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/srep26094","volume":"6","author":"R Miotto","year":"2016","unstructured":"Miotto, R., Li, L., Kidd, B. A. & Dudley, J. T. Deep patient: an unsupervised representation to predict the future of patients from the electronic health records. Sci. Rep. 6, 26094 (2016).","journal-title":"Sci. Rep."},{"key":"381_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-018-0029-1","volume":"1","author":"A Rajkomar","year":"2018","unstructured":"Rajkomar, A. et al. Scalable and accurate deep learning with electronic health records. NPJ Digit. Med. 1, 18 (2018).","journal-title":"NPJ Digit. Med."},{"key":"381_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41746-017-0012-2","volume":"1","author":"AL Fogel","year":"2018","unstructured":"Fogel, A. L. & Kvedar, J. C. Artificial intelligence powers digital medicine. NPJ Digit. Med. 1, 1\u20134 (2018).","journal-title":"NPJ Digit. Med."},{"key":"381_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41746-017-0013-1","volume":"1","author":"A Madani","year":"2018","unstructured":"Madani, A., Arnaout, R., Mofrad, M. & Arnaout, R. Fast and accurate view classification of echocardiograms using deep learning. NPJ Digit. Med. 1, 1\u20138 (2018).","journal-title":"NPJ Digit. Med."},{"key":"381_CR32","unstructured":"Katsuki, T. et al. Feature extraction from electronic health records of diabetic nephropathy patients with convolutioinal autoencoder. In The Workshops of the Thirty-Second AAAI Conference on Artificial Intelligence, (ed. McIlraith S.), (AAAI, 2018)."},{"key":"381_CR33","unstructured":"Jaques, N., Taylor, S., Sano, A. & Picard, R. In 2017 Seventh International Conference on Affective Computing and Intelligent Interaction (ACII) 202\u2013208 (IEEE, 2017)."},{"key":"381_CR34","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.1016\/j.jmb.2018.05.037","volume":"430","author":"S Pai","year":"2018","unstructured":"Pai, S. & Bader, G. D. Patient similarity networks for precision medicine. J. Mol. Biol. 430, 2924\u20132938 (2018).","journal-title":"J. Mol. Biol."},{"key":"381_CR35","doi-asserted-by":"publisher","first-page":"311ra174","DOI":"10.1126\/scitranslmed.aaa9364","volume":"7","author":"L Li","year":"2015","unstructured":"Li, L. et al. Identification of type 2 diabetes subgroups through topological analysis of patient similarity. Sci. Transl. Med. 7, 311ra174 (2015).","journal-title":"Sci. Transl. Med."},{"key":"381_CR36","unstructured":"Kipf, T. N. & Welling, M. Semi-supervised classification with graph convolutional networks. In The International Conference on Learning Representations (eds. Bengio, Y. & LeCun, Y.) (ICLR, 2017)."},{"key":"381_CR37","unstructured":"Zhou, J. et al. Graph neural networks: a review of methods and applications. Preprint at https:\/\/arxiv.org\/abs\/1812.08434 (2018)."},{"key":"381_CR38","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1001\/jama.2019.3241","volume":"321","author":"G Singal","year":"2019","unstructured":"Singal, G. et al. Association of patient characteristics and tumor genomics with clinical outcomes among patients with non\u2013small cell lung cancer using a clinicogenomic database. JAMA 321, 1391\u20131399 (2019).","journal-title":"JAMA"},{"key":"381_CR39","unstructured":"Wang, C., Pan, S., Long, G., Zhu, X. & Jiang, J. In Proceedings of the 2017 ACM on Conference on Information and Knowledge Management 889\u2013898 (ACM, 2017)."},{"key":"381_CR40","first-page":"2579","volume":"9","author":"Lvd Maaten","year":"2008","unstructured":"Maaten, Lvd & Hinton, G. Visualizing data using t-SNE. J. Mach. Learn. Res. 9, 2579\u20132605 (2008).","journal-title":"J. Mach. Learn. Res."},{"key":"381_CR41","doi-asserted-by":"crossref","unstructured":"McInnes, L., Healy, J. & Melville, J. Umap: uniform manifold approximation and projection for dimension reduction. Preprint at https:\/\/arxiv.org\/abs\/1802.03426 (2018).","DOI":"10.21105\/joss.00861"},{"key":"381_CR42","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/BF01908075","volume":"2","author":"L Hubert","year":"1985","unstructured":"Hubert, L. & Arabie, P. Comparing partitions. J. Classification 2, 193\u2013218 (1985).","journal-title":"J. Classification"},{"key":"381_CR43","doi-asserted-by":"publisher","first-page":"703","DOI":"10.21037\/tlcr.2018.08.14","volume":"7","author":"M Allg\u00e4uer","year":"2018","unstructured":"Allg\u00e4uer, M. et al. Implementing tumor mutational burden (TMB) analysis in routine diagnostics\u2014a primer for molecular pathologists and clinicians. Transl. Lung Cancer Res. 7, 703 (2018).","journal-title":"Transl. Lung Cancer Res."},{"key":"381_CR44","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.1158\/1535-7163.MCT-17-0386","volume":"16","author":"AM Goodman","year":"2017","unstructured":"Goodman, A. M. et al. Tumor mutational burden as an independent predictor of response to immunotherapy in diverse cancers. Mol. Cancer Ther. 16, 2598\u20132608 (2017).","journal-title":"Mol. Cancer Ther."},{"key":"381_CR45","unstructured":"U.S. Food and Drug Administration. FDA approves atezolizumab for first-line treatment of metastatic NSCLC with high PD-L1 expression. http:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-atezolizumab-first-line-treatment-metastatic-nsclc-high-pd-l1-expression (2020)."},{"key":"381_CR46","unstructured":"U.S. Food and Drug Administration. FDA expands pembrolizumab indication for first-line treatment of NSCLC (TPS \u22651%). http:\/\/www.fda.gov\/drugs\/fda-expands-pembrolizumab-indication-first-line-treatment-nsclc-tps-1 (2019)."},{"key":"381_CR47","unstructured":"U.S. Food and Drug Administration. FDA approves nivolumab plus ipilimumab for first-line mNSCLC (PD-L1 tumor expression \u22651%). http:\/\/www.fda.gov\/drugs\/drug-approvals-and-databases\/fda-approves-nivolumab-plus-ipilimumab-first-line-mnsclc-pd-l1-tumor-expression-1 (2020)."},{"key":"381_CR48","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1007\/s12094-018-1908-2","volume":"21","author":"T Karantanos","year":"2019","unstructured":"Karantanos, T., Karanika, S., Seth, B. & Gignac, G. The absolute lymphocyte count can predict the overall survival of patients with non-small cell lung cancer on nivolumab: a clinical study. Clin. Transl. Oncol. 21, 206\u2013212 (2019).","journal-title":"Clin. Transl. Oncol."},{"key":"381_CR49","doi-asserted-by":"crossref","unstructured":"Kargl, J. et al. Neutrophil content predicts lymphocyte depletion and anti-PD1 treatment failure in NSCLC. JCI Insight 4 (2019).","DOI":"10.1172\/jci.insight.130850"},{"key":"381_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40425-018-0447-2","volume":"6","author":"AE Soyano","year":"2018","unstructured":"Soyano, A. E. et al. Peripheral blood biomarkers correlate with outcomes in advanced non-small cell lung Cancer patients treated with anti-PD-1 antibodies. J. Immunother. Cancer 6, 1\u20139 (2018).","journal-title":"J. Immunother. Cancer"},{"key":"381_CR51","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.jtho.2019.01.011","volume":"14","author":"A Jeanson","year":"2019","unstructured":"Jeanson, A. et al. Efficacy of immune checkpoint inhibitors in KRAS-mutant non-small cell lung cancer (NSCLC). J. Thorac. Oncol. 14, 1095\u20131101 (2019).","journal-title":"J. Thorac. Oncol."},{"key":"381_CR52","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.canlet.2019.10.027","volume":"470","author":"C Liu","year":"2020","unstructured":"Liu, C. et al. The superior efficacy of anti-PD-1\/PD-L1 immunotherapy in KRAS-mutant non-small cell lung cancer that correlates with an inflammatory phenotype and increased immunogenicity. Cancer Lett. 470, 95\u2013105 (2020).","journal-title":"Cancer Lett."},{"key":"381_CR53","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.cell.2018.05.061","volume":"174","author":"D van Dijk","year":"2018","unstructured":"van Dijk, D. et al. Recovering gene interactions from single-cell data using data diffusion. Cell 174, 716\u2013729. e727 (2018).","journal-title":"Cell"},{"key":"381_CR54","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nbt.4096","volume":"36","author":"A Butler","year":"2018","unstructured":"Butler, A., Hoffman, P., Smibert, P., Papalexi, E. & Satija, R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 36, 411\u2013420 (2018).","journal-title":"Nat. Biotechnol."},{"key":"381_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-019-1663-x","volume":"20","author":"FA Wolf","year":"2019","unstructured":"Wolf, F. A. et al. PAGA: graph abstraction reconciles clustering with trajectory inference through a topology preserving map of single cells. Genome Biol. 20, 59 (2019).","journal-title":"Genome Biol."},{"key":"381_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-019-1812-2","volume":"20","author":"Y Baran","year":"2019","unstructured":"Baran, Y. et al. MetaCell: analysis of single-cell RNA-seq data using K-nn graph partitions. Genome Biol. 20, 206 (2019).","journal-title":"Genome Biol."},{"key":"381_CR57","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart, T. et al. Comprehensive integration of single-cell data. Cell 177, 1888\u20131902.e1821 (2019).","journal-title":"Cell"},{"key":"381_CR58","doi-asserted-by":"crossref","unstructured":"Wang, J. et al. scGNN: a novel graph neural network framework for single-cell RNA-Seq analyses. Preprint at https:\/\/www.biorxiv.org\/content\/10.1101\/2020.08.02.233569v1 (2020).","DOI":"10.1101\/2020.08.02.233569"},{"key":"381_CR59","doi-asserted-by":"crossref","unstructured":"Song, Q., Su, J. & Zhang, W. scGCN: a graph convolutional networks algorithm for knowledge transfer in single cell omics. Preprint at https:\/\/www.biorxiv.org\/content\/10.1101\/2020.09.13.295535v1.full (2020).","DOI":"10.1101\/2020.09.13.295535"},{"key":"381_CR60","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1631\/jzus.B1100382","volume":"13","author":"L Yang","year":"2012","unstructured":"Yang, L. et al. Nkx2-1: a novel tumor biomarker of lung cancer. J. Zhejiang Univ. Sci. B 13, 855\u2013866 (2012).","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"381_CR61","doi-asserted-by":"publisher","unstructured":"Wang, F., Kaushal, R. & Khullar, D. Should health care demand interpretable artificial intelligence or accept \u201cblack box\u201d medicine? Ann. Intern. Med. https:\/\/doi.org\/10.7326\/M19-2548 (2019).","DOI":"10.7326\/M19-2548"},{"key":"381_CR62","unstructured":"Veli\u010dkovi\u0107, P. et al. Graph attention networks. The International Conference on Learning Representations (eds. Bengio, Y. & LeCun Y.) (ICLR, 2018)."},{"key":"381_CR63","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41746-019-0148-3","volume":"2","author":"P Shah","year":"2019","unstructured":"Shah, P. et al. Artificial intelligence and machine learning in clinical development: a translational perspective. NPJ Digit. Med. 2, 69 (2019).","journal-title":"NPJ Digit. Med."},{"key":"381_CR64","unstructured":"Gottlieb, S. Transforming FDA\u2019s approach to digital health. https:\/\/www.fda.gov\/news-events\/speeches-fda-officials\/transforming-fdas-approach-digital-health-04262018 (2018)."},{"key":"381_CR65","unstructured":"U.S. FDA. Software as a medical device. https:\/\/www.fda.gov\/MedicalDevices\/DigitalHealth\/SoftwareasaMedicalDevice\/ucm20086412.htm (2018)."},{"key":"381_CR66","unstructured":"FDA. Digital Health Innovation Action Plan. https:\/\/www.fda.gov\/media\/106331\/download (2018)."},{"key":"381_CR67","unstructured":"U.S. FDA. FDA permits marketing of artificial intelligence-based device to detect certain diabetes-related eye problems. https:\/\/www.fda.gov\/newsevents\/newsroom\/pressannouncements\/ucm604357.htm (2018)."},{"key":"381_CR68","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.jacr.2019.04.023","volume":"16","author":"B Allen","year":"2019","unstructured":"Allen, B., Agarwal, S., Kalpathy-Cramer, J. & Dreyer, K. Democratizing AI. J. Am. Coll. Radiol. 16, 961\u2013963 (2019).","journal-title":"J. Am. Coll. Radiol."},{"key":"381_CR69","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41551-018-0305-z","volume":"2","author":"KH Yu","year":"2018","unstructured":"Yu, K. H., Beam, A. L. & Kohane, I. S. Artificial intelligence in healthcare. Nat. Biomed. Eng. 2, 719\u2013731 (2018).","journal-title":"Nat. Biomed. Eng."},{"key":"381_CR70","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/s41591-018-0029-3","volume":"24","author":"DSW Ting","year":"2018","unstructured":"Ting, D. S. W. et al. AI for medical imaging goes deep. Nat. Med. 24, 539\u2013540 (2018).","journal-title":"Nat. Med."},{"key":"381_CR71","doi-asserted-by":"crossref","unstructured":"Li, G., Muller, M., Thabet, A. & Ghanem, B. DeepGCNs: can GCNs go as deep as CNNs? In Proc. IEEE International Conference on Computer Vision (eds. Lee, K. M., Forsyth, D., Pollefeys, M. & Tang, X.) 9267\u20139276 (IEEE, 2019).","DOI":"10.1109\/ICCV.2019.00936"},{"key":"381_CR72","unstructured":"Yang, C., Wang, R., Yao, S., Liu, S. & Abdelzaher, T. Revisiting \u201cOver-smoothing\u201d in deep GCNs. Preprint at https:\/\/arxiv.org\/pdf\/2003.13663.pdf (2020)."},{"key":"381_CR73","doi-asserted-by":"crossref","unstructured":"Chen, D. et al. Measuring and relieving the over-smoothing problem for graph neural networks from the topological view. In The Thirty-Fourth AAAI Conference on Artificial Intelligence, 3438\u20133445 (AAAI, 2020).","DOI":"10.1609\/aaai.v34i04.5747"},{"key":"381_CR74","unstructured":"Wang, C., Pan, S., Long, G., Zhu, X. & Jiang, J. In Proc. 2017 ACM on Conference on Information and Knowledge Management (eds. Lim, E. P. & Winslett, M.) (Association for Computing Machinery, Singapore, Singapore, 2017)."},{"key":"381_CR75","unstructured":"Bianchi, F. M., Grattarola, D. & Alippi, C. In Proc. 37th International Conference on Machine Learning (eds. Singh, A., Ill, H. D. & Blei, D.) (PMLR, 2020)."},{"key":"381_CR76","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1136\/bmj.317.7172.1572","volume":"317","author":"JM Bland","year":"1998","unstructured":"Bland, J. M. & Altman, D. G. Survival probabilities (the Kaplan-Meier method). BMJ 317, 1572 (1998).","journal-title":"BMJ"},{"key":"381_CR77","unstructured":"Fleming, T. R. & Harrington, D. P. Counting Processes and Survival Analysis Vol. 169 (John Wiley & Sons, 2011)."},{"key":"381_CR78","unstructured":"Romesburg, H. C. Cluster Analysis for Researchers (Lulu, 2004)."},{"key":"381_CR79","doi-asserted-by":"publisher","first-page":"1257601","DOI":"10.1126\/science.1257601","volume":"347","author":"J Menche","year":"2015","unstructured":"Menche, J. et al. Disease networks. Uncovering disease-disease relationships through the incomplete interactome. Science 347, 1257601 (2015).","journal-title":"Science"},{"key":"381_CR80","unstructured":"Han, J., Pei, J. & Kamber, M. Data Mining: Concepts and Techniques (Elsevier, 2011)."},{"key":"381_CR81","doi-asserted-by":"publisher","DOI":"10.1038\/srep29915","volume":"6","author":"H Chen","year":"2016","unstructured":"Chen, H. et al. Relational network for knowledge discovery through heterogeneous biomedical and clinical features. Sci. Rep. 6, 29915 (2016).","journal-title":"Sci. Rep."}],"container-title":["npj Digital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41746-021-00381-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-021-00381-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-021-00381-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T12:09:02Z","timestamp":1674907742000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41746-021-00381-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,2]]},"references-count":81,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["381"],"URL":"https:\/\/doi.org\/10.1038\/s41746-021-00381-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/19011437","asserted-by":"object"}]},"ISSN":["2398-6352"],"issn-type":[{"value":"2398-6352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,2]]},"assertion":[{"value":"26 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14"}}